Eli Lilly’s experimental oral weight reduction tablet helped sufferers lose about 12 p.c of their physique weight on common in a late-stage trial, the corporate stated Thursday, constructive outcomes however nonetheless lower than its injectable opponents. Lilly’s inventory was down greater than 14 p.c on the day after the outcomes had been introduced. After 72 weeks, sufferers taking the best dose of the drug, known as orforglipron, misplaced a median …
|